Great move! If it was a penny stock, I would have been more cautious of the drop as you immediately suspect "R/S has been announced". But with Pharmas, especially when it comes to FDA decisions at bay, any big drop (even if it is due to a denial) typically rebounds somewhat.
Market Data 
Markets 
AI
